Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc" Results 81 - 100 of 245
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jul 2014, 6:31 pm by Kristin Casler
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]). [read post]
11 Feb 2013, 4:37 am by Susan Brenner
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
30 Oct 2007, 11:28 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), to challenge the reliability of that testimony. [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]
24 Jan 2013, 8:09 am by Alex Craigie
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579), federal courts have applied a different standard. [read post]
6 May 2013, 5:16 am by Susan Brenner
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
14 Jul 2015, 6:41 am by Ellen Houston
Merrell Dow Pharmaceuticals, Inc., the landmark case that sets forth the test for the admissibility of expert testimony. [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]
27 Dec 2012, 5:07 am by Erin Kristofco
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593-94 (1993) are relevant to the Court’s reliability determination under CRE 702, which is identical to FRE 702. [read post]
27 May 2010, 3:40 pm by Bexis
Merrell Dow Pharmaceuticals, Inc., 791 F. [read post]
21 Aug 2006, 3:14 pm
Merrell Dow Pharmaceuticals, Inc. articulated an entirely new set of criteria based on the scientific method for the admissibility of expert testimony. [read post]
28 Dec 2017, 2:18 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]